Single Cell Analysis of Cross Talk Among Kinase Pathways
激酶通路间串扰的单细胞分析
基本信息
- 批准号:6999728
- 负责人:
- 金额:$ 30.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-01-01 至 2008-12-31
- 项目状态:已结题
- 来源:
- 关键词:biological signal transductioncell differentiationcell lineelectrostimulusenzyme activityenzyme induction /repressionguanine nucleotide binding proteinhigh performance liquid chromatographymitogen activated protein kinaseneoplastic growthoncoprotein p21phosphatidylinositol 3 kinaseprotein kinaseprotein protein interactionprotein tyrosine kinasesingle cell analysistissue /cell culturewestern blottings
项目摘要
DESCRIPTION (provided by applicant): Interacting cascades of signaling proteins, particularly kinases, play crucial roles in the development and maintenance of cancer. Despite their importance in oncogenic signal transduction pathways, little is understood about the biochemical behavior of these proteins within the context of the living cell. It is now clear that these signaling cascades are not merely a linear series of enzymatic reactions leading from discrete stimuli to defined cellular responses. Rather, they are interrelated in complex networks such that their biochemical properties within the living cell are not intuitive. Traditional biochemical studies that rely on lysates of bulk cell populations cannot decipher the inherent properties of cell signaling due to averaging of heterogeneous cellular responses across the population. To understand such biochemical phenomena as cross-talk between pathways, thresholds of activation and bistable states, kinase assays must be performed in intact, single cells. The current work is directed at decoding the biochemical behaviors of the Ras-related pathways- signaling pathways of particular import to cancer biology. These studies will apply a powerful new technology for kinase assays in single cells to a unique series of tumor cell lines possessing constitutively active or inactive signaling proteins. The cell lines (human HT1080/MCH603 fibrosarcoma and mouse NIH3T3) display a range of tumorigenic characteristics dependent on the repertoire of constitutive activity in Ras-related signaling pathways. In mass populations of MCH603 cells our data support the notion that the threshold behavior and crosstalk among these pathways closely relate to the relative aggressiveness of their tumorigenic phenotype. The current studies will reveal how the behavior of signaling cascades involving the kinases phosphoinositide-3-kinase (PI3K), Akt, p21-activated kinase and Erk1/2 interrelate in living, single cells. The specific aims for this project are to 1) determine whether induction of crosstalk, generated by P13K activity, requires a threshold level of activated PI3K; 2) determine if cross-activation of these kinase pathways is coordinate or sequential; and 3) determine if cross-talk activation of MAP kinase cascades is reversible or irreversible after withdrawal of the PI3K or Akt stimulus. These studies will provide additional information relating to our understanding of the consequences of activation of kinase signaling pathways with respect to malignant transformation, aggressive tumor growth and survival.
描述(由申请人提供):信号蛋白(特别是激酶)的相互作用级联在癌症的发展和维持中起关键作用。尽管它们在致癌信号转导途径中的重要性,但对这些蛋白质在活细胞中的生物化学行为知之甚少。现在清楚的是,这些信号级联不仅仅是从离散刺激到确定的细胞反应的线性系列酶促反应。相反,它们在复杂的网络中相互关联,使得它们在活细胞内的生化特性不是直观的。传统的生物化学研究依赖于大量细胞群的裂解物,由于整个群体的异质细胞反应的平均化,因此无法破译细胞信号传导的固有特性。为了理解这样的生化现象,如通路之间的串扰、激活阈值和激活状态,激酶测定必须在完整的单细胞中进行。目前的工作是针对解码Ras相关途径的生化行为-对癌症生物学特别重要的信号传导途径。这些研究将为单细胞激酶测定提供一种强大的新技术,用于一系列独特的肿瘤细胞系,这些肿瘤细胞系具有组成性活性或非活性信号蛋白。细胞系(人HT 1080/MCH 603纤维肉瘤和小鼠NIH 3 T3)显示出一系列依赖于Ras相关信号通路组成性活性的致瘤特征。在大量的MCH 603细胞群体中,我们的数据支持这样的观点,即这些通路之间的阈值行为和串扰与其致瘤表型的相对侵袭性密切相关。目前的研究将揭示涉及激酶磷酸肌醇-3-激酶(PI 3 K),Akt,p21激活激酶和Erk 1/2的信号级联的行为如何在活的单细胞中相互关联。该项目的具体目的是:1)确定P13 K活性产生的串扰诱导是否需要活化PI 3 K的阈值水平; 2)确定这些激酶途径的交叉活化是协调的还是顺序的; 3)确定在PI 3 K或Akt刺激撤销后MAP激酶级联的串扰活化是可逆的还是不可逆的。这些研究将为我们理解激酶信号通路激活对恶性转化、侵袭性肿瘤生长和生存的影响提供更多信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC J. STANBRIDGE其他文献
ERIC J. STANBRIDGE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC J. STANBRIDGE', 18)}}的其他基金
Single Cell Analysis of Cross Talk Among Kinase Pathways
激酶通路间串扰的单细胞分析
- 批准号:
7178789 - 财政年份:2005
- 资助金额:
$ 30.53万 - 项目类别:
Single Cell Analysis of Cross Talk Among Kinase Pathways
激酶通路间串扰的单细胞分析
- 批准号:
7324436 - 财政年份:2005
- 资助金额:
$ 30.53万 - 项目类别:
Single Cell Analysis of Cross Talk Among Kinase Pathways
激酶通路间串扰的单细胞分析
- 批准号:
6872729 - 财政年份:2005
- 资助金额:
$ 30.53万 - 项目类别:
Single Cell Analysis of Cross Talk Among Kinase Pathways
激酶通路间串扰的单细胞分析
- 批准号:
7055189 - 财政年份:2005
- 资助金额:
$ 30.53万 - 项目类别:
DOMINANT-NEGATIVE AND GAIN OF FUNCTION P53 MUTATIONS
P53 显性失活和功能获得突变
- 批准号:
6164194 - 财政年份:1996
- 资助金额:
$ 30.53万 - 项目类别:
DOMINANT-NEGATIVE AND GAIN OF FUNCTION P53 MUTATIONS
P53 显性失活和功能获得突变
- 批准号:
2882426 - 财政年份:1996
- 资助金额:
$ 30.53万 - 项目类别:
EVALUATION OF DOMINANTLY-ACTING RAS ONCOGENES
对起主导作用的 RAS 癌基因的评估
- 批准号:
2668028 - 财政年份:1996
- 资助金额:
$ 30.53万 - 项目类别:
DOMINANT-NEGATIVE AND GAIN OF FUNCTION P53 MUTATIONS
P53 显性失活和功能获得突变
- 批准号:
2376977 - 财政年份:1996
- 资助金额:
$ 30.53万 - 项目类别:
EVALUATION OF DOMINANTLY-ACTING RAS ONCOGENES
对起主导作用的 RAS 癌基因的评估
- 批准号:
2113574 - 财政年份:1996
- 资助金额:
$ 30.53万 - 项目类别:
EVALUATION OF DOMINANTLY-ACTING RAS ONCOGENES
对起主导作用的 RAS 癌基因的评估
- 批准号:
6459503 - 财政年份:1996
- 资助金额:
$ 30.53万 - 项目类别:
相似海外基金
Hedgehog signalling in T-cell differentiation and function
T 细胞分化和功能中的 Hedgehog 信号传导
- 批准号:
BB/Y003454/1 - 财政年份:2024
- 资助金额:
$ 30.53万 - 项目类别:
Research Grant
Comparative single-cell analysis of disease-derived stem cells to identify the cell fate defect on the cell differentiation trajectory
对疾病来源的干细胞进行比较单细胞分析,以确定细胞分化轨迹上的细胞命运缺陷
- 批准号:
23H02466 - 财政年份:2023
- 资助金额:
$ 30.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The role of cell differentiation in colorectal cancer progression
细胞分化在结直肠癌进展中的作用
- 批准号:
23K06661 - 财政年份:2023
- 资助金额:
$ 30.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dissecting the role of hypoxia in T cell differentiation in cancer
剖析缺氧在癌症 T 细胞分化中的作用
- 批准号:
10578000 - 财政年份:2023
- 资助金额:
$ 30.53万 - 项目类别:
Mechanisms mediating human enteroendocrine cell differentiation and function
介导人肠内分泌细胞分化和功能的机制
- 批准号:
10739834 - 财政年份:2023
- 资助金额:
$ 30.53万 - 项目类别:
TOX-driven CD8 T cell differentiation and dysfunction in tumors
TOX驱动的肿瘤中CD8 T细胞分化和功能障碍
- 批准号:
10586679 - 财政年份:2023
- 资助金额:
$ 30.53万 - 项目类别:
Elucidation of molecular mechanisms of immune cell differentiation of a novel Rab protein in hematopoietic stem cells
阐明造血干细胞中新型Rab蛋白免疫细胞分化的分子机制
- 批准号:
23K16122 - 财政年份:2023
- 资助金额:
$ 30.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
New strategies in cell replacement therapies for diabetes: role of USP7 in iPSC and adult organoids beta cell differentiation
糖尿病细胞替代疗法的新策略:USP7 在 iPSC 和成体类器官 β 细胞分化中的作用
- 批准号:
MR/X01813X/1 - 财政年份:2023
- 资助金额:
$ 30.53万 - 项目类别:
Research Grant
Role of alveolar fibroblasts in extracellular matrix organization and alveolar type 1 cell differentiation
肺泡成纤维细胞在细胞外基质组织和肺泡1型细胞分化中的作用
- 批准号:
10731854 - 财政年份:2023
- 资助金额:
$ 30.53万 - 项目类别:
Exhaustive Identification of Essential Genes for Human Taste Cell Differentiation ~Development of a Method for Inducing Differentiation of Taste Buds from ES/iPS Cells~
彻底鉴定人类味觉细胞分化必需基因~开发诱导ES/iPS细胞味蕾分化的方法~
- 批准号:
23K09214 - 财政年份:2023
- 资助金额:
$ 30.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)